Drug intelligence / Profile preview

bailing jianpi granules

Development stage: Unknown
Lead developer: Guoguang Pharmaceutical
Administration: Oral

Overview

Bailing Jianpi Granules (白苓健脾颗粒) is a traditional Chinese medicine (TCM) developed and manufactured by Hangzhou Guoguang Pharmaceutical, marketed under the brand name Lexingren (乐星人). It is specifically formulated as oral granules for pediatric use. The medication is indicated for strengthening the spleen and harmonizing the stomach (健脾和胃), and is primarily used to treat children suffering from anorexia, indigestion, and loose stools caused by spleen and stomach weakness. As a TCM product, it utilizes a multi-herbal approach to regulate gastrointestinal function and improve nutrient absorption in children.

Brand names: Lexingren乐星人
Other names: 白苓健脾颗粒Bailing Jianpi Keli

Beyond the preview

Go deeper on bailing jianpi granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bailing jianpi granules.

Explore the full profile